As has happened in many other medical specialties, anaesthesia has been transformed from an art into a science due to our increased understanding of the pharmacology of the drugs employed. The practice of anaesthesia with inhalation anaesthetics, including anaesthetic gases and vapours, also requires our understanding of the pharmacokinetics of anaesthetic uptake. This understanding becomes quite critical when we start to reduce the fresh gas flow from high to low flow, then from low flow to the minimal flow of closed circuit anaesthesia.
The practice of closed circuit anaesthesia demands, in principle, that the supply of inhalation anaesthetics matches the consumption or uptake by the patient. Therefore, to practise closed circuit anaesthesia, one should fully understand the mechanism of anaesthetic uptake. It is necessary only to supply the amounts of anaesthetic vapour that the patient requires or absorbs. Yet serious misunderstandings about the mechanism of uptake have dominated the anaesthesia literature in the past, and this has made the practice of closed circuit anaesthesia difficult.
The most important misunderstandings are related to the actual process of uptake. Often, we fail to exclude the amount of anaesthetic required initially to fill the space outside the alveolar membrane from the total uptake measured at the mouthpiece. This causes confusion as to the correct pharmacokinetics of inhalation anaesthetics and makes it difficult to practise closed circuit anaesthesia. The ill effect of this misunderstanding is not limited to the practice of closed circuit anaesthesia; almost the entire practice of anaesthesia with inhalation anaesthetics has been affected. For example, the second gas effect is based on the premise of initial uptake of large amounts of nitrous oxide, which either requires an increase in the inflow of anaesthetic gas or causes the gas already existing in the alveoli to become concentrated. Diffusion hypoxia is a concept that assumes initial washout of large quantities of nitrous oxide, which creates dilution of oxygen in the alveoli during the period of recovery from anaesthesia. Both concepts assume that large quantities of nitrous oxide cross the alveolar membrane when either nitrous oxide is introduced or its administration is interrupted. But, no matter how high the concentration of nitrous oxide given, a limited amount is taken up across the alveolar membrane during washin because of the initial dilution by the gases pre-existing in the FRC.
The concept of minimum alveolar concentration (MAC) has been utilised in operating theatres since its introduction in 1964, as a standard measure of potency of anaesthetics and of the depth of anaesthesia. The goal of inhalation anaesthesia is to develop and maintain a satisfactory partial pressure or tension of anaesthetic at the site of anaesthetic action, the brain. Despite this goal, the concept of MAC to define the standard of potency or the depth of anaesthesia neglects the time required for equilibration in its definition (the time is mentioned only in the method of determination of MAC). The definition of MAC only states that it is the alveolar concentration of an anaesthetic at 1 atm which prevents a response to a painful stimulus in 50070 of subjects. This definition does not incorporate the time required for the anaesthetic concentration in the brain to reach equilibrium with the alveolar concentration. We almost always misjudge the depth of anaesthesia because we use the partial pressure of an anaesthetic in the alveoli instead of the partial pressure in the brain as a measure.
Uptake of gases and vapour has been described in the past by many physiologists on the basis of common sense and sound physiologic principles. However, when we look at the published anaesthesia literature on the actual process of uptake of inhalational anaesthetics, it is difficult to understand this process in simple terms. We, as anaesthesiologists, should not forget common sense and apply physiologic principles to the study of uptake of anaesthetics. This paper presents information on the uptake of anaesthetic gas and vapour based on common sense and basic physiology which is different from that found in textbooks.
RECOGNITION OF FUNCTIONAL RESIDUAL CAPACITY AS DEADSPACE OR EXTENSION OF THE ANAESTHETIC CIRCUIT
When the anaesthesia circuit is connected to the patient, we have to consider the existence of a large gaseous space before the alveolar membrane, namely, the functional residual capacity (FRC) or residual volume (RV) of the lung. The FRC or RV of the lung is not a collapsible space; therefore, gas exchange must take place when an anaesthetic gas is introduced into the patient. This exchange requires a few minutes, according to the relationship between the size of the FRC and the alveolar ventilation. With the use of a high-concentration, high-volume anaesthetic gas such as nitrous oxide, some of the gas will be expelled from the circuit during the processes of washin and washout.
In 1954, Severinghaus published an article! on measurement of nitrous oxide uptake in six volunteers. He expressed the rate of nitrous oxide uptake over time as a power function of time, 1000 (ml) x t (min)-1I2. This suggests that nitrous oxide uptake will be very high in the first few minutes. According to this function, at the one-minute time point, the rate of nitrous oxide uptake will be 1000 mllmin ( Figure 1 ) and, from the start of anaesthesia to the end of the first minute, the average patient has absorbed or taken up 2000 ml of nitrous oxide. Subsequently, Lowe 2 and Mapleson' similarly approximated the uptake of halothane to the power function 100 (ml) t-l12 (min). However, the approximations made in the derivation of these t-1I2 functions, in fact, do not separate the FRC from the true body uptake. In considering uptake of an inhalation anaesthetic, one should include only the amount of inhalational anaesthetic crossing the alveolar membrane and not the amount measured at the mouthpiece.
When we carried out a simple experiment" to measure the true uptake of nitrous oxide from the alveolar membrane ( Figure 2 ), we obtained a picture that differed from that previously presented by Severinghaus. We did an experiment in which we used a subtraction method. During constant-volume ventilation, inspiratory-expiratory concentration differences represent uptake if one assumes that complete mixing of gases occurs in the lungs. For determination of nitrous oxide uptake, we obtained inspiratory and expiratory nitrous oxide concentration curves when nitrous oxide and oxygen were introduced into a circle system with patient attached. With the same ventilatory rate, ventilatory volume, and fresh gas flow, we then carried out an in vitro washin experiment with the FRC of the patient simulated by a reservoir bag. Subtraction of the expired nitrous oxide concentration during According to this function, at the one-minute time point, the rate of uptake will be 1000 mllmin and, from the start of anaesthesia to the end of the first minute, the average patient has taken up 2000 ml of nitrous oxide. The rate of uptake at the four-minute time point will be 500 mllmin, and at the nine-minute time point it will be 333 mllmin.
I n Vitro
In Vivo torr O 2 torr FIGURE 2: Mass-spectrometric tracings obtained in vitro and in vivo, designed to demonstrate the importance of recognition of the functional residual capacity as deadspace or extension of the circuit. In considering uptake of nitrous oxide, one should consider only the amount of nitrous oxide crossing the alveolar membrane and not the amount measured at the mouthpiece. In vitro and in vivo washin experiments were carried out with the same ventilatory rate, ventilatory volume, and fresh-gas flow. In the in vitro experiment, the FRC of the patient was matched by a reservoir bag. Differences in inspiratory-expiratory nitrous oxide concentration, usually an indicator of nitrous oxide uptake, were large initially both in vitro and in vivo. However, the differences disappeared within five minutes of initiation, indicative of FRC washin and not of the amount of nitrous oxide taken up across the alveolar membrane.
washin into the simulated lung from the expired concentration measured in vivo yielded the net nitrous oxide concentration difference due to actual body uptake of the gas across the alveolar membrane ( 3). The figure shows that uptake of nitrous oxide started from zero volume and not from an infinite volume as expressed in the power function ( Figure 4 ). This can be explained by the fact that the inspired concentration of an anaesthetic cannot immediately reach a peak at the alveolar level because the anaesthetic gas is diluted by the gases pre-existing in the FRC. Uptake of nitrous oxide reaches its highest level when the process of FRC washin has been completed, about three minutes from the starting point.
To provide more proof of limited nitrous oxide uptake even at high inspired concentrations, we carried out several experiments. In Figure 5 , we try to demonstrate indirectly from measurement on a patient that, initially, nitrous oxide uptake is limited in amount because of the existence of the FRC and the alveolar membrane. After complete preoxygenation, 1500 mllmin of nitrous oxide and 200 mllmin of oxygen were introduced. After six minutes at this level, the nitrous oxide concentration at the expiratory side of the circuit reached 60070. With 1500 mllmin nitrous oxide introduced into 3000 ml FRC and 6000 ml circuit volume (a total of 9000 ml), after one time constant of six minutes the nitrous oxide concentration will be 63% if none of the nitrous oxide is absorbed. The expiratory nitrous oxide concentration reached nearly 63%, which indicates that very limited nitrous oxide uptake occurred in this six-minute period. If nitrous oxide uptake depends on the square root of time, there should be a slower rise in the expired concentration of nitrous oxide. During washin of certain anaesthetic gases into the FRC, especially with a large volume or high concentration of an anaesthetic gas such as nitrous oxide, exchanges with gases pre-existing in the FRC take place on a volume-by-volume basis. After FRC washin, the given anaesthetic concentration is reached at the alveolar level, and probably the greatest difference between the inspired level of anaesthetic and the level in mixed venous blood is generated at this time. From then on, with the rise in anaesthetic concentration in mixed venous blood, the gradient between inspired and mixed venous blood concentrations at the alveolar membrane is reduced, and this reduces the rate of uptake. Because the rise in the mixed venous anaesthetic concentration is a rather slow process, the rate of uptake does not change significantly with time.
RECOGNITION OF THE ALVEOLAR MEMBRANE AS A BARRIER Application of Fick's Principle
The process of uptake at the level of the alveolar membrane is passive in nature. In fact, at the alveolar membrane level, anaesthesiologists are able to control the amount of anaesthetic uptake by manipulating the inspired concentration. The higher the inspired anaesthetic concentration, the greater the amount of anaesthetic that will be picked up by the blood flowing through the lungs. Similar to any respiratory physiologic process, uptake of inhalation anaesthetics must follow the Fick principle of alveolar membrane penetration 5 ,7. Fick's principle describes the rate of penetration as
x Diffusion constant Area of membrane (area is proportional to pulmonary capillary flow or cardiac output) Solubility coefficient Thickness of membrane Inspired anaesthetic concentration at alveoli Mixed venous anaesthetic concentration Thus the Fick principle emphasises that uptake is concentration-dependent, and that the uptake of an inhalation anaesthetic depends mainly on three factors: the partial pressure gradient (Cl and CB), the bloodgas solubility coefficient of the anaesthetic gas, and the cardiac output (area of membrane). We will refer to this principle later in discussing effective blood concentration.
FAIF[
If we looked at the relationship between alveolar concentration and inspired concentration of an anaesthetic, we agree with a previous publication by Eger8 in which he described the relationship of F A/FI to the blood-gas solubility coefficient; however, in considering uptake of an inhalation anaesthetic, we differ from the idea of Eger ( Figure 6 ). First, the previous publication failed to recognise the existence of the alveolar membrane and only took two elements-the solubility coefficient and the partial pressure gradient across the membrane-from the Fick principle to explain uptake. As shown in Figure 6 , when we compared the rate of rise of F A/FI for nitrous oxide in a patient by using an in vitro breath-by-breath calculation, we demonstrated that there is a great difference between the measurement and calculations based only on the solubility coefficient. Second, the rate of rise and the curve of F A/FI itself do not represent uptake. We realise that it is impossible to place the measurement probe just outside the alveolar membrane; we are forced to measure uptake at the mouthpiece. Therefore, the uptake of an anaesthetic, when measured at the mouthpiece, should be expressed as the difference between inspired and expired concentration except during the initial washin period". As a result, the rate of uptake after washin should be expressed as the value above the curve of F A/FI vs time, represented by 1-F A/FI (fraction of uptake), and not as the value of F A/FI itself (Figure 7 ). Thus, the The curve on the left was published by Eger, and we provide an explanation on the right. The initial rise in F A/FJ indicates FRC washin and not a fast build-up of the mixed venous anaesthetic concentration to oppose uptake. Since inspiratory and expiratory anaesthetic concentration differences indicate the anaesthetic uptake during constant-volume ventilation, the rate of true body uptake should be represented by the dotted area, which shows very limited change over 1 h. The uptake is best expressed by the area above the F A/Fr curve and not by the F A/FJ curve itself. The initial lower rate of uptake can be explained by the fact that the inspired concentration of nitrous oxide cannot reach a peak at the alveolar level because nitrous oxide is diluted by the gases pre-existing in the FRC. The shaded area on the right indicates FRC washin. fractional nitrous oxide uptake at a given time can be expressed as:
Fraction of uptake = 1-F A/FI. (2) The same principle can be applied to other inhalation anaesthetics; the fraction-of-uptake curve for halothane is shown in Figure 8 and that for enflurane in Figure 9 . The curve for isoflurane is very similar to that for enflurane because of the similarity in their solubility coefficients ( Figure 10 ). The curve for the new inhalation anaesthetic desflurane is shown in Figure  11 . Despite the similarity of the blood-gas solubility coefficient of 0.42 to that of nitrous oxide (0.47), the curve for F A/FI of desflurane is lower than that for nitrous oxide (Figure 12 ). The concentration effect has been used to explain this reverse phenomenon ID. But this explanation became invalid when an equal inspired concentration of anaesthetic gas was used for comparison. Therefore, the demonstrated lower F A/FI curve of desflurane is mainly a result of differences in the tissue-blood solubility coefficients and not the result of the concentration effect. Because of the higher tissue-blood solubility coefficient of desflurane, more desflurane than nitrous oxide will be taken up in a given time interval at the tissue level, with resulting lower mixed venous anaesthetic concentration of desflurane. This in turn, increases the anaesthetic concentration difference between inspired gas and that in mixed venous blood and increases the fraction of uptake, 1-F A/FI, of desflurane over that for nitrous oxide.
Calculation of Uptake of Anaesthetic Vapour
The above mentioned formula for uptake at a given time, 1-F A/FI, which can also be expressed as Cl/CA (where CA is the expired concentration), does not contain the volume of gas. Since the alveolar ventilation is directly involved in the concentration difference or the fraction of uptake, the rate of uptake (see Figure  6 ) can be expressed as:
Inspired concentration x Fraction of uptake x Alveolar ventilation or FA . This dramatically different viewpoint on the subject of uptake from that expressed by Eger (who directly used the solubility coefficient and cardiac output in the calculation of uptake) has a significant impact on the practice of anaesthesia, particularly closed circuit anaesthesia, in several ways. First, the uptake of an inhalation anaesthetic is concentration-dependent; this indicates that 3010 inspired concentration provides three times more uptake at a given time when compared with 1 % inspired concentration. (One should eliminate the word "pressurising" used in the previous literature and change to "inspired-concentration-dependent uptake" instead.) Second, from this expression we now can calculate the rate of uptake after washin in very simple terms. For example, in adult patients, for 1 % halothane, the rate of uptake is, according to the above expression, 11100 x (1-0.5) x 3000 mllmin = 15 mllmin. When 1.5010 of inspired halothane is given, the rate of uptake will be increased to 22.5 mllmin: 1.5/100 x (1-0.5) x 3000 = 22.5 mllmin. In these calculations, we are able to use a single value for alveolar ventilation in adults to calculate the uptake, because the alveolar ventilation : F A/FI curves for desflurane and nitrous oxide. The blood-gas solubility coefficient of desflurane (0.42) is less than that of nitrous oxide (0.47). However, the alveolar rate of rise toward the inspired concentration is faster for nitrous oxide than for desflurane because desflurane has a higher tissue-blood solubility coefficient than does nitrous oxide, which will reduce the rate of rise of anaesthetic concentration in mixed venous blood.
does not directly enter into the Fick principle of the rate of penetration (eq. 1). This is illustrated below.
As shown by Eger 11 and by others 12.13, when the alveolar ventilation increases, the curve for F A/FI vs time will rise. This suggests that the fractional uptake (1-F A/FI) will decrease when the ventilation increases, thus resulting in no net change in the rate of uptake (Figure 13 ). On the other hand, a decrease in ventilation results in an increase in the fractional uptake, and again, no net change in the rate of uptake will take place. Therefore, respiration or alveolar ventilation per se does not directly participate in the process of uptake or play an indirect or supporting role in uptake. When we examined the relationship of alveolar anaesthetic concentration to the inspired anaesthetic concentration, we also found that the fraction of uptake, 1-F A/FI, does not change significantly with time at a constant inspired anaesthetic concentration. This means that the rate of uptake at a given anaesthetic concentration will be near-constant. However, as mentioned before, if the inspired concentration increases, the rate of uptake increases. Actual measurements of nitrous oxide uptake at different inspired concentrations prove that increasing the concentration will, in fact, result in an increase in uptake ( Figure 14 ).
In the case of closed circuit anaesthesia, once the circuit has been primed to a certain anaesthetic concentration, this concentration can thus be maintained with easy administration of anaesthetic vapour at approximately a constant rate, based on the simple dose calculation just described. Even if considered from the beginning of anaesthesia induction, the volume of anaesthetic taken up does not change significantly from one minute to the next when the inspired concentration remains constant. When the uptake of 50070 inspired nitrous oxide was measured in 30 patients 14, there was less than 100 ml of uptake across the alveolar membrane in the first minute of administration. This uptake increased to more than 200 ml in the second minute and reached a peak of approximately 250 ml in the third minute. From this peak, the uptake steadily declined to about 140 ml after one hour.
In the past, the practice of closed circuit anaesthesia FIGURE 14: Rate of nitrous oxide uptake measured using asubtraction method as described in the text in 50 patients who were undergoing open-heart surgery. Twenty patients received 600/0 nitrous oxide and 30 patients received 50% nitrous oxide. The rate of uptake reached its peak at the 3rd min and then declined very slowly during the 1st h. At the higher inspired concentration (60%), the rate of uptake was higher. (Reprinted from Lin CY: Can we practice safe, simple closed-circuit anesthesia without extensive monitoring or calculations? In closed-circuit system and other innovation in anesthesia. Droh R, Spintge R, eds, 1986, Springer-Verlag with permission.) was unpopular because anaesthesiologists had difficulty in dispensing the anaesthetic into the closed circuit according to the dose calculation based on a power function of time. With the above changes in viewpoint regarding the pharmacokinetics of inhalation anaesthetic uptake, the practice of closed circuit anaesthesia becomes easy, safe, and more readily understandable.
Problems Associated with Previous Concepts
Most of the published equations related to the pharmacokinetics of uptake of inhalation anaesthetics look exclusively at uptake from the demand side and not from the supply side. Also, they ignore the existence of the alveolar membrane and the tissue-capillary interface. The passive nature of uptake of inhalation anaesthetics is quite different from the pharmacokinetics of intravenous anaesthetics. When an inhalation anaesthetic for which the dose was calculated from the t -1/2 function was delivered into the anaesthesia circuit, this led to a prohibitively high inspired anaesthetic concentration that often caused severe depression of the cardiovascular system. If one uses the MAC concept l5 (although I disagree with the use of the concept other than for the final anaesthetic concentration), one can calculate the total amount of vapour (in ml) required to reach the desired anaesthetic concentration in the blood as: MAC x Abl/g x blood volume, where BIG is the blood-gas solubility coefficient.
In the case of halothane and a 5000 ml blood volume, the halothane vapour requirement for the blood to reach the MAC level of 0.76070 will be: 0.76 x 2.3 x 50 = 87.4 m!.
How we are able to supply and reach the desired level in blood depends on the concentration of halothane that exists at the alveoli. If we provide 2070 halothane at a reasonable alveolar ventilation and cardiac output, the estimated halothane uptake is 30 mllmin (see above). At this rate, approximately three minutes are required for the blood concentration of halothane to reach the MAC level. However, in these calculations the distribution of anaesthetic gas to the organs has been ignored completely. If we use 1 % halothane, the desired blood level will be reached in six minutes. Thus, a higher anaesthetic concentration will reduce the time required for the desired blood concentration to be reached. However, a higher anaesthetic concentration will sometimes depress the myocardium by a bolus effect of the anaesthetic, and less anaesthetic will be taken up by the blood from then on. When the anaesthetic level in the blood reaches the desired value, saturation of the brain concentration to that blood level will depend on the blood flow distribution to the brain, the tissue-blood solubility coefficient, and the volume of brain tissue.
For the brain to reach the same anaesthetic concentration as that in the blood usually requires more than 15 minutes, but depends on the tissue-blood solubility coefficient of the agent used. The normal adult brain weighs about 2100 g. For example, in the case of halothane, with a flow of 1000 mllmin and a brain tissue-to-blood solubility coefficient of 2.9, one time constant for the brain to reach the same halothane concentration as that in the blood will be: 2100 x 2.9/1000 = 6.09 min. (It should be noted that this simple calculation of the time constants does not include the membrane barrier as mentioned in the previous sections; the actual time required for true equilibration would be much longer.)
In the case of isoflurane, one time constant for the brain will be: 2100 x 2.6/1000 = 5.46 min. However, in the case of desflurane, which has a much lower brain tissue-blood solubility coefficient, one time constant for the brain is much shorter: 2100 X 1.29/1000 = 2.71 min, which indicates that a much shorter time is required for the brain to reach the desired concentration or partial pressure of desflurane than for halothane or isoflurane when an equipotent inspired anaesthetic concentration is provided.
During the time of induction, the circulating blood will deliver anaesthetic to the other blood-rich organs and to some organs with an intermediate blood supply, and the amount of anaesthetic required will be about two to three times that required for the blood to reach a desirable anaesthetic concentration in blood vessel-rich organs such as the brain. The amount of halothane vapour required for establishing anaesthesia (i.e., for MAC) will be about 300 to 400 ml as compared with 87.4 ml for blood only. This is why we frequently use a 2.5 % to 3 % inspired halothane concentration for 10 minutes during induction and then drop the inspired concentration to 1 % to anaesthetize a patient in a semiclosed circuit. As shown above, a 1 % inspired halothane concentration gives a halothane vapour uptake rate of 15 mllmin. In clinical practice, however, the anaesthetic concentration is often adjusted to the individual haemodynamic response and does not merely follow a programmed dose schedule.
During induction of anaesthesia with inhalation anaesthetics, unstable haemodynamic changes are often encountered because of misunderstandings about uptake. When anaesthetics at high concentration are introduced into the circuit, the myocardium will be suppressed because of the high anaesthetic concentration in blood which reaches the myocardium first. The brain requires a much longer time constant in order to equilibrate to the alveolar concentration. In the past, a quantitative approach often was not used. Therefore, despite a very low brain anaesthetic concentration, it was believed that the patient was anaesthetized because of a sharp drop in blood pressure and an increase in the alveolar anaesthetic concentration. Subsequent stimulation, such as application of a laryngoscope and endotracheal intubation, causes stormy haemodynamic changes, and sometimes this extraordinary stress to the heart may result in permanent damage. Thus, in the case of critically ill patients who require haemodynamic stability during induction, induction of anaesthesia with inhalation anaesthetics requires special precautions, avoiding high inspired anaesthetic concentrations and requiring a longer induction time in order to achieve a satisfactory anaesthetic concentration in the brain.
Effective Blood Concentration (EBC)
The goal of inhalation anaesthesia is to develop and maintain a satisfactory partial pressure or tension of anaesthetic at the site of anaesthetic action, the brain. As mentioned above, the time required for the brain to equilibrate with the alveolar concentration requires more than 15 minutes, but differs with different anaesthetists. This problem is compounded by the fact that the arterial blood does not quickly equilibrate with the alveolar tension of an anaesthetic 16 , and thus equilibration with the brain is further delayed.
The use of MAC to define the depth of anaesthesia during induction in clinical practice is impractical. The level of alveolar concentration is usually determined from the inspired anaesthetic concentration during induction, and a substantial partial pressure gradient exists between alveoli and arteries at any given time. As mentioned before, in order to achieve equilibrium concentration between arterial and brain anaesthetic concentrations requires more than 15 minutes; therefore, it is not possible to define the depth of anaesthesia from the alveolar concentration alone without defining the time. With the recognition of the membrane barrier, we are able to develop the concept of effective blood concentration (EBC), which eliminates the time constraint of MAC and presents the depth of anaesthesia in a more physiologic and pharmacologic way. The new concept uses the concentration of anaesthetic in mixed venous blood to represent the brain concentration. The mixed venous anaesthetic concentration always represents more than 750/0 of the total saturated condition of the blood-rich organ group, which includes the brain. This new concept uses the physiologic principles proposed by Fick, as discussed earlier.
The alveolar membrane separates the inhaled anaesthetic gas in the alveoli from the mixed venous blood flowing through the pulmonary capillaries. Any gases that penetrate the alveolar membrane and are picked up by the pulmonary capillary blood flow must obey (1)
If we assume that the pulmonary capillary flow (cardiac output) does not change, then, for a given anaesthetic, DAk/x can be considered to be constant and can be represented by a membrane factor, K. The equation can then be simplified, and the rate of uptake of an inhalation anaesthetic as measured at the alveolar membrane level can be expressed as: K(CI -CB). (4) When we measure the uptake of an inhalation anaesthetic at the mouthpiece in each breathing cycle with constant ventilation and constant cardiac output, the rate of uptake is a function of the inspiratory (CO-expiratory (CA) anaesthetic concentration difference: (5) Since (4) and (5) both represent the rate of uptake of an anaesthetic, although they are measured at different levels, we can combine (4) and (5):
Cl -CA =K(CI -CB).
(6) Now we can rewrite the equation as: (7) During the initial introduction of an inhalation anaesthetic, we can determine the membrane factor K for an individual by substituting CB =0 at the end of FRC washin and from the measured inspired (Cl) and expired (CA) anaesthetic concentrations. Then:
At any stage of anaesthesia, after a brief period of washin into the FRC, we can now re-utilise equation (6) These formulae were tested in 10 mongrel dogs anaesthetised with 25 mg/kg pentobarbital. Cardiac output was monitored for constancy by an electromagnetic flow probe placed by thoracotomy and ventilation was controlled using nitrous oxide, oxygen with halothane. Mixed venous samples were obtained through a Swan-Ganz catheter introduced through a jugular vein. The blood samples were analysed for halothane using a gas chromatograph.
Our result of the correlation between determinations made on the mixed venous blood and that calculated using the mass spectrometer was approximately 0.9 (Figure 15 ). Modern anaesthesia practice often consists of monitoring of anaesthetic agents in which the inspiratory and expiratory concentrations of the anaesthetic are displayed. However, with little change in the circuit board of the monitoring equipment, a continuous display of the estimated mixed venous blood concentration of an anaesthetic is possible with the use of equation (6).
CONCLUSION
With the acceptance of two basic concepts, namely, the recognition of the functional residual capacity as deadspace or extension of the circuit, and the recognition of the alveolar membrane as a barrier, we gain a better and clearer understanding of the actual process of uptake. With the use of the Fick principle, we are able to define the membrane factor K after FRC washin. This approach also provides a better understanding of the fact that uptake depends on the inspired concentration of an anaesthetic. When we critically analysed the relationship between alveolar concentration and inspired concentration of an anaesthetic, F AIFI, we realised that the rate of uptake after FRC washin should be expressed as the value above the curve of F AIFI vs time, represented by the fraction of uptake 1-F AIFI, and not as the curve for F AIFI itself. With a proper understanding of the curve for FAIFI vs time, we now are able to use equation (3) to estimate the uptake of an anaesthetic quantitatively. Finally, with application of the Fick principle, we also are able to derive a formula (Equation 8) with which one can estimate the anaesthetic concentration in mixed venous blood without the need for blood sampling.
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